GlassScriptPhysician profile
Kimble C Poon
NPI 1376747410
$1,588.41
in general payments reported to CMS, 2019-2025
11 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $198 · 2021: $68.94 · 2022: $161 · 2023: $81.52 · 2024: $286 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $655.96 | 2019-2025 | Accolade Sr, General - Brady, Cds - Mct/Cem Monitoring |
| Edwards Lifesciences Corporation | $276.53 | 2020-2024 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $201.34 | 2019 | |
| Medtronic, INC. | $185.80 | 2022-2023 | Plasmablade(Tm) |
| Abiomed | $91.26 | 2024 | Impella |
| Gilead Sciences, INC. | $63.25 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.82 | 2019-2024 | Lifevest |
| Abbott Laboratories | $24.11 | 2020 | |
| Medicomp INC | $19.79 | 2025 | Telepatch Cardiac Monitor |
| Astellas Pharma US INC | $16.40 | 2021 | |
| Penumbra, INC. | $16.15 | 2024 | Ruby Coil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimble Poon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.